Elicera Therapeutics (OMX: ELIC)

Last close As at 28/10/2025

SEK5.88

−0.12 (−2.00%)

Market capitalisation

SEK286m

Elicera Therapeutics is a Sweden-based clinical-stage cell and gene therapy company focused on developing next generation immuno-oncology treatments based on iTANK-armed oncolytic viruses and CAR-T cells.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Ingvar Karlsson

    CFO

  • Jamal El-Mosleh

    CEO and co-founder

Thematics